Cryo-Cell International, Inc. (CCEL)
 NYSEAMERICAN: CCEL · Real-Time Price · USD
 4.490
 -0.020 (-0.44%)
  Nov 3, 2025, 4:00 PM EST - Market closed
Cryo-Cell International Market Cap
Cryo-Cell International has a market cap or net worth of $36.17 million as of November 4, 2025. Its market cap has decreased by -28.24% in one year.
Market Cap 
 36.17M
Enterprise Value 
 45.54M
1-Year Change 
 -28.24%
Ranking 
 Category 
 Stock Price 
$4.49
Market Cap Chart
Since December 1, 1998, Cryo-Cell International's market cap has increased from $21.70M to $36.17M, an increase of 66.67%. That is a compound annual growth rate of 1.91%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 31, 2025 | 36.30M | -39.20% | 
| Dec 31, 2024 | 59.70M | 25.42% | 
| Dec 29, 2023 | 47.60M | 32.22% | 
| Dec 30, 2022 | 36.00M | -63.60% | 
| Dec 31, 2021 | 98.90M | 70.22% | 
| Dec 31, 2020 | 58.10M | 4.50% | 
| Dec 31, 2019 | 55.60M | -4.96% | 
| Dec 31, 2018 | 58.50M | -14.85% | 
| Dec 29, 2017 | 68.70M | 121.61% | 
| Dec 30, 2016 | 31.00M | 6.90% | 
| Dec 31, 2015 | 29.00M | 21.34% | 
| Dec 31, 2014 | 23.90M | 20.10% | 
| Dec 31, 2013 | 19.90M | -14.96% | 
| Dec 31, 2012 | 23.40M | -0.43% | 
| Dec 30, 2011 | 23.50M | -16.67% | 
| Dec 31, 2010 | 28.20M | 34.93% | 
| Dec 31, 2009 | 20.90M | 326.53% | 
| Dec 31, 2008 | 4.90M | -46.74% | 
| Dec 31, 2007 | 9.20M | -65.28% | 
| Dec 29, 2006 | 26.50M | -32.91% | 
| Dec 30, 2005 | 39.50M | -19.22% | 
| Dec 31, 2004 | 48.90M | 431.52% | 
| Dec 31, 2003 | 9.20M | -50.27% | 
| Dec 31, 2002 | 18.50M | -65.80% | 
| Dec 31, 2001 | 54.10M | 132.19% | 
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 772.59B | 
| Johnson & Johnson | 455.04B | 
| AbbVie | 385.18B | 
| UnitedHealth Group | 309.40B | 
| AstraZeneca | 253.98B | 
| Novartis AG | 237.13B | 
| Novo Nordisk | 216.87B | 
| Abbott Laboratories | 214.96B |